Luseogliflozin

Luseogliflozin

Cat. No.: DIA-0243335

Size: 100 mg Size: 200 mg Size: 500 mg Size: Customer Size
Product Information
CAS No. 898537-18-3
Synonyms TS 071
Formula C23H30O6S
Molecular Weight 434.55
SMILES OC[C@@H](S1)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1C2=C(OC)C=C(C)C(CC3=CC=C(OCC)C=C3)=C2
Target SGLT
Product Description Luseogliflozin (TS 071) is a potent, selective, orally active sodium-dependent glucose cotransporter (SGLT) 2 inhibitor, with an IC50 of 2.26 nM, about 1765-fold selectivity over SGLT1 (IC50, 3990 nM). Luseogliflozin has the protential for researching type 2 diabetes.
Format & Storage
Format Solid
Color White to off-white
Purity 99.20%
Shipping Room temperature in the continental U.S. Other areas may vary.
Storage In solvent: -80°C, 6 months; -20°C, 1 month (protect from light)
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
logo

Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links
Contact Info
Copyright © Ace Therapeutics. All Rights Reserved.
Top